Baseline ventilatory function predicts the development of higher levels of fasting insulin and fasting insulin resistance index: the Normative Aging Study.

A consistent but as yet unexplained association between baseline ventilatory function and risk of coronary heart disease (CHD) has been reported from many prospective studies. Insulin-resistant states are associated with increased risk of CHD. Forced vital capacity (FVC), forced expiratory volume in one second (FEV1) and maximal mid-expiratory flow rate (MMEF) at study entry were examined as predictors for indirect measures of insulin resistance after a mean follow-up interval of 20.9 yrs in 1050 nondiabetic male subjects in the Normative Aging Study. Males in the top quintile of insulin or fasting insulin resistance index (FIRI) levels at follow-up were defined as being relatively insulin resistant. FVC was negatively associated with risk of being relatively insulin resistant using the insulin (p=0.002) or FIRI (p=0.0001) criteria at follow-up in logistic regression models adjusting for baseline age, body mass index, fat distribution pattern and cigarette smoking. Similar associations were found for FEV1 and MMEF. Additional adjustment for baseline postcarbohydrate challenge glucose levels made little difference to the results, suggesting that baseline glucose intolerance was not a significant source of bias. These findings are consistent with the possibility that insulin resistance may be one of the factors mediating the previously unexplained prospective association between impairment of ventilatory function and risk of mortality from coronary heart disease.

[1]  S. Prato,et al.  FIRI: fasting or false insulin resistance index? , 1996, The Lancet.

[2]  H. Wedel,et al.  Peak expiratory flow and risk of cardiovascular disease and death. A 12-year follow-up of participants in the population study of women in Gothenburg, Sweden. , 1986, American journal of epidemiology.

[3]  P. Savage,et al.  Exploration of simple insulin sensitivity measures derived from frequently sampled intravenous glucose tolerance (FSIGT) tests. The Insulin Resistance Atherosclerosis Study. , 1995, American journal of epidemiology.

[4]  K. Yano,et al.  Distribution and correlates of insulin in elderly men. The Honolulu Heart Program. , 1995, Arteriosclerosis, thrombosis, and vascular biology.

[5]  M. J. Toth,et al.  Body fatness and waist circumference are independent predictors of the age-associated increase in fasting insulin levels in healthy men and women. , 1995, International journal of obesity and related metabolic disorders : journal of the International Association for the Study of Obesity.

[6]  A. Buist.  Standardization of spirometry. , 1987, The American review of respiratory disease.

[7]  P. Whincup,et al.  Serum insulin and incident coronary heart disease in middle-aged British men. , 1996, American journal of epidemiology.

[8]  E. Fletcher,et al.  The effect of body fat distribution on pulmonary function tests. , 1995, Chest.

[9]  R. Lazarus,et al.  Effects of obesity and fat distribution on ventilatory function: the normative aging study. , 1997, Chest.

[10]  T H Beaty,et al.  Impaired pulmonary function as a risk factor for mortality. , 1982, American journal of epidemiology.

[11]  J. Schoenberg,et al.  Growth and decay of pulmonary function in healthy blacks and whites. , 1978, Respiration physiology.

[12]  R. DeFronzo,et al.  Insulin Resistance: A Multifaceted Syndrome Responsible for NIDDM, Obesity, Hypertension, Dyslipidemia, and Atherosclerotic Cardiovascular Disease , 1991, Diabetes Care.

[13]  P. Björntorp.  The regulation of adipose tissue distribution in humans. , 1996, International journal of obesity and related metabolic disorders : journal of the International Association for the Study of Obesity.

[14]  M. Laakso,et al.  Decreased effect of insulin to stimulate skeletal muscle blood flow in obese man. A novel mechanism for insulin resistance. , 1990, The Journal of clinical investigation.

[15]  P. Schnohr,et al.  Ventilatory function impairment and risk of cardiovascular death and of fatal or non-fatal myocardial infarction. , 1991, The European respiratory journal.

[16]  P. Schnohr,et al.  Diabetes mellitus and ventilatory capacity: a five year follow-up study. , 1990, The European respiratory journal.

[17]  R. Summers,et al.  Resistance to metabolic actions of insulin and its role in hypertension. , 1994, American journal of hypertension.

[18]  M. Laakso,et al.  How good a marker is insulin level for insulin resistance? , 1993, American journal of epidemiology.

[19]  A. Siegelaub,et al.  Lung function and risk of myocardial infarction and sudden cardiac death. , 1976, The New England journal of medicine.

[20]  W. Kannel,et al.  Vital capacity as a predictor of cardiovascular disease: the Framingham study. , 1983, American heart journal.

[21]  Albert Damon,et al.  The Normative Aging Study: An Interdisciplinary and Longitudinal Study of Health and Aging , 1972 .

[22]  R. C. Kory,et al.  The Veterans Administration-Army cooperative study of pulmonary function. I. Clinical spirometry in normal men. , 1961, The American journal of medicine.

[23]  [Population study of women in Gothenburg]. , 1981, Lakartidningen.

[24]  A. Buist,et al.  Correlates of FEV1 and prevalence of pulmonary conditions in Japanese-American men. , 1988, The American review of respiratory disease.

[25]  J. Kastrup,et al.  Diabetes mellitus, plasma glucose and lung function in a cross-sectional population study. , 1989, The European respiratory journal.

[26]  N. Owen,et al.  Effects of body composition and fat distribution on ventilatory function in adults. , 1998, The American journal of clinical nutrition.

[27]  W. Willett,et al.  Anthropometric Measures and Body Composition , 1998 .

[28]  J. Connell,et al.  FIRI: a fair insulin resistance index? , 1996, The Lancet.

[29]  P. Sweetnam,et al.  Simple measure of insulin resistance , 1995, The Lancet.